TY - JOUR
T1 - Determinants of Self-reported Health Outcomes in Adrenal Insufficiency
T2 - A Multisite Survey Study
AU - Li, Dingfeng
AU - Genere, Natalia
AU - Behnken, Emma
AU - Xhikola, Majlinda
AU - Abbondanza, Tiffany
AU - Vaidya, Anand
AU - Bancos, Irina
N1 - Publisher Copyright:
© 2020 The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved.
PY - 2021/3/1
Y1 - 2021/3/1
N2 - Context: Current evidence on determinants of adverse health outcomes in patients with adrenal insufficiency (AI) is scarce, especially in regards to AI subtypes. Objective: To determine predictors of adverse outcomes in different subtypes of AI. Design and Setting: Cross-sectional survey study at 2 tertiary centers. Participants: A total of 696 patients with AI: primary AI (PAI, 42%), secondary AI (SAI, 32%), and glucocorticoid-induced AI (GIAI, 26%). Intervention: Patient-centered questionnaire. Main Outcome Measures: Patients' knowledge, self-management of AI, self-perceived health, and adverse outcomes. Results: The incidence rate of adrenal crisis was 24/100 patient-years with 44% experiencing at least 1 adrenal crisis since diagnosis (59% in PAI vs 31% in SAI vs 37% in GIAI, P <. 0001). All patients described high degrees of discomfort with self-management and receiving prompt treatment. Patients with PAI were most likely to develop adrenal crises (adjusted OR 2.8, 95% CI 1.9-4.0) despite reporting better self-perceived health (adjusted OR 3.3, 95% CI 2.1-5.3), understanding of their diagnosis (89% vs 74-81% in other subtypes, P =. 002), higher comfort with self-management (62% vs 52-61% in other sub types, P =. 005), and higher likelihood to receive prompt treatment for adrenal crises in the emergency department (42% vs 19-30% in other subtypes, P <. 0001). Conclusions: Patients with AI reported high degrees of discomfort with self-management and treatment delays when presenting with adrenal crises. Despite better self-perceived health and understanding of diagnosis, patients with PAI experienced the highest frequency of adrenal crises. A multidimensional educational effort is needed for patients and providers to improve the outcomes of all subtypes of AI.
AB - Context: Current evidence on determinants of adverse health outcomes in patients with adrenal insufficiency (AI) is scarce, especially in regards to AI subtypes. Objective: To determine predictors of adverse outcomes in different subtypes of AI. Design and Setting: Cross-sectional survey study at 2 tertiary centers. Participants: A total of 696 patients with AI: primary AI (PAI, 42%), secondary AI (SAI, 32%), and glucocorticoid-induced AI (GIAI, 26%). Intervention: Patient-centered questionnaire. Main Outcome Measures: Patients' knowledge, self-management of AI, self-perceived health, and adverse outcomes. Results: The incidence rate of adrenal crisis was 24/100 patient-years with 44% experiencing at least 1 adrenal crisis since diagnosis (59% in PAI vs 31% in SAI vs 37% in GIAI, P <. 0001). All patients described high degrees of discomfort with self-management and receiving prompt treatment. Patients with PAI were most likely to develop adrenal crises (adjusted OR 2.8, 95% CI 1.9-4.0) despite reporting better self-perceived health (adjusted OR 3.3, 95% CI 2.1-5.3), understanding of their diagnosis (89% vs 74-81% in other subtypes, P =. 002), higher comfort with self-management (62% vs 52-61% in other sub types, P =. 005), and higher likelihood to receive prompt treatment for adrenal crises in the emergency department (42% vs 19-30% in other subtypes, P <. 0001). Conclusions: Patients with AI reported high degrees of discomfort with self-management and treatment delays when presenting with adrenal crises. Despite better self-perceived health and understanding of diagnosis, patients with PAI experienced the highest frequency of adrenal crises. A multidimensional educational effort is needed for patients and providers to improve the outcomes of all subtypes of AI.
KW - adrenal crisis
KW - diagnosis
KW - glucocorticoid therapy
KW - healthcare delivery
KW - management
UR - http://www.scopus.com/inward/record.url?scp=85102497841&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgaa668
DO - 10.1210/clinem/dgaa668
M3 - Article
C2 - 32995875
AN - SCOPUS:85102497841
SN - 0021-972X
VL - 106
SP - E1408-E1419
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 3
ER -